LCTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Lineage Cell Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.22 USD 0.83% Market Closed

Market Cap: $304.1m

L	Lineage Cell Therapeutics Inc AMEX:LCTX	US
	LNA Sante SA F:2N3	FR
A	Akwel SA SWB:MW4	FR
	Groupon Inc NASDAQ:GRPN	US
	RH F:RS1	US
N	New China Life Insurance Co Ltd XBER:NCL	CN
H	Haulotte Group SA XBER:PHT	FR
	China Oilfield Services Ltd SSE:601808	CN
	DSV A/S CSE:DSV	DK
	Cisco Systems Inc NASDAQ:CSCO	US
N	NameSilo Technologies Corp CNSX:URL	CA
	Kinatico Ltd ASX:KYP	AU

Profitability Summary

Lineage Cell Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Strong 3Y Average Gross Margin

95%

Gross Margin is Increasing

94% > 99%

Negative Operating Margin

-150%

Negative 3Y Average Operating Margin

-249%

Operating Margin is Increasing

-223% > -150%

Negative Net Margin

-436%

Negative 3Y Average Net Margin

-312%

Declining Net Margin

-209% > -436%

Negative Free Cash Flow Margin

-134%

Negative 3Y Average Free Cash Flow Margin

-267%

Free Cash Flow Margin is Increasing

-304% > -134%

Negative ROE

-103%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-37%

ROIC is Increasing

-36% > -34%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.